More Drama At Sarepta Therapeutics (SRPT) As Chairman Of The Board Abruptly Steps Down, Interim Chairman Named
As Sanofi (France) (SAN.PA) Pushes to Grow Faster, A Top U.S. Exec Is Leaving
Benefit Of Baxter International, Inc. (BAX)'s Immune Therapy Outweighs Risk: FDA Panel
Menlo Park's Avalanche Biotechnologies (AAVL) Rolls Onto Nasdaq, Raises $102 Million For Its IPO
Regeneron Pharmaceuticals, Inc. (REGN), Sanofi (France) (SAN.PA) Bag BioMarin Pharmaceutical Inc. (BMRN)'s Special FDA Priority Review Voucher For $67.5 Million
Novartis AG (NVS) Apologizes For Not Disclosing Side-Effects Of Leukemia Drugs Sooner
AstraZeneca PLC (AZN) Steps Up Push Into Cancer Immunotherapy, Falls Behind Rivals Such As Bristol-Myers Squibb Company (BMY), Merck & Co., Inc. (MRK), And Roche (RHHBY)
Flailing Dendreon Corporation (DNDN) Brings In Ex-Johnson & Johnson (JNJ) Exec For Top CEO Post
FDA Panel Reviews Safety Of Baxter International, Inc. (BAX)'s Experimental Drug For Immune System Disorders
Meda AB (MEDA-A.ST) Bags Rottapharm $3.08 Billion To Create A European Pharma Powerhouse
FDA Approves Boehringer Ingelheim Pharmaceuticals, Inc.'s Once-A-Day Inhaler Drug Striverdi For Chronic Lung Disease Patients
Cambridge-Based Gen9 Gets $25 Million In Equity Funding For DNA Synthesis
SoCal Biopharma Cold Genesys, Inc. Locks In $13.57 Million Series A
Sanofi (France) (SAN.PA) Second Quarter Profit Jumps 73 Percent; Earnings Outlook Lifted
Catalent Pharma Solutions (CTLT) Prices IPO At Midpoint Range, Raises $871 Million
Epilepsy Biotech Marinus Pharmaceuticals (MRNS) Prices IPO At $10/Share
Israeli Biotech Macrocure Sets Terms for $75 Million IPO
50 Jobs Promised As Stem Cell Company Precious Cells BioBank Gets Bigger
See All News >
Amgen (AMGN) Eliminating Up To 2,900 Jobs; Will Shutter Seattle, Bothell Sites
Allergan Inc. (AGN) Layoffs: Employees Tell Their Side Of The Story
Rumor: Sarepta Therapeutics (SRPT) Chairman Moves To Keep CEO Out Of FDA Meetings
Three Things To Take Away From Amgen (AMGN)'s Big Restructuring
GlaxoSmithKline (GSK) May Separate Businesses
Regeneron Pharmaceuticals, Inc. (REGN), Sanofi (France) (SAN.PA) Drug Alirocumab Cuts Cholesterol In Nine Late-Stage Trials
BioPharm Executive: Have Drugs Finally Been Priced Too High?
Amid Cuts, Amgen (AMGN) To Add Jobs In Cambridge, Massachusetts
Incyte Corporation (INCY) Partners With Genentech (RHHBY) To Help With Cancer Immunotherapy Trials
AstraZeneca PLC (AZN) Scoops Up Almirall Lung Drugs For Up To $2.1 Billion
Pfizer Inc. (PFE) Grabs Baxter International, Inc. (BAX)'s Portfolio Of Marketed Vaccines For $635 Million
Pfizer Inc. (PFE) CEO Aggressively Seeking Deals, Leaves Investors Guessing On AstraZeneca PLC (AZN) Intentions
IMPAX Laboratories, Inc. (IPXL) Parkinson's Drug Future Shaky As FDA Cites Factory Issues
Second Failure Of The Month As Targacept, Inc. (TRGT) Halts Development Of Bladder Drug, Shares Plunge
Novartis AG (NVS) Layoffs: Game-Changing Tips For Today’s Job Seeker
Pfizer Inc. (PFE)'s Need For A Deal Looms Larger As Second Quarter Profits Sinks 79 Percent
Drinking In Midlife Doubles Chance Of Memory Problems In Later Life, University of Exeter Study
Wide-Faced Men Negotiate Nearly $2,200 Larger Signing Bonus, University of California, Riverside Study
See All News >
//-->